Stockholm, 4th of October 2021 – Sanolium AB, parent of the Cambio Group (“Cambio” or “the Company”) operating entities, today announces that its Board of Directors has named Rami Avidan as Chief Executive Officer with effect from 4th of October 2021.

Rami Avidan has extensive experience from the tech industry where he has successfully led large and complex product organizations. Most recently Rami Avidan was CEO at Deutche Telecom and prior to that he was CEO at Tele2 IoT.We are very happy to welcome Rami to Cambio. Rami is well known for his leadership skills and with his experience from leading large international companies he will be an important player on our continued growth journey says Tomas Mora-Morrison, co-founder and Board Director of Cambio.

– I appreciate the trust given by the Board of Directors, and I am really excited to join Cambio, a company that are in the business to improve healthcare and that are well positioned to bring even more value to healthcare and society. Our focus going forward will be to deliver on our promises and to continue our growth journey by finding new ways of serving our customers with even more value says Rami Avidan

– This information is information that Sanolium AB(publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 10:50 am CEST on 19 April 2021.

For further information, please contact:

Jenny Styren
Chief Marketing & Communication Officer
+46 7 0 79 34 83

About Sanolium
Sanolium AB, parent of the Cambio Group (“Cambio” or “the Company”) operating entities, is an e-health company providing comprehensive IT solutions to improve healthcare and patient safety. Cambio is one of the largest suppliers in Scandinavia and a growing player in the European market, with more than 170,000 users across regions and municipalities, general and university hospitals, health centers and specialist units. Cambio has offices in Sweden, Denmark, United Kingdom and Sri Lanka.